Intellectual Property Cases filed in Delaware
Cases 31 - 40 of 141
Novartis Pharmaceuticals Corporation v. Dr. Reddys Laboratories, Inc. et al
as 1:2019cv02053
Defendant: MSN Laboratories Private Limited, Dr. Reddys Laboratories, Inc., Hetero USA Inc. and others
Plaintiff: Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 271
Pfizer Inc. et al v. Mylan Pharmaceuticals Inc.
as 1:2019cv01863
Plaintiff: Warner-Lambert Company LLC, PF Prism C.V., Pfizer Manufacturing Holdings LLC and others
Defendant: Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271
Janssen Pharmaceuticals, Inc. et al v. Mylan Laboratories Limited et al
as 1:2019cv01488
Plaintiff: Janssen Pharmaceutica NV and Janssen Pharmaceuticals, Inc.
Defendant: Mylan Pharmaceuticals Inc., Mylan Laboratories Limited and Mylan Institutional LLC
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation v. Mylan Pharmaceuticals, Inc.
as 1:2019cv01118
Defendant: Mylan Pharmaceuticals, Inc.
Plaintiff: Novartis Pharmaceuticals Corporation
Cause Of Action: 28 U.S.C. § 2201
Anacor Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc. et al
as 1:2019cv00632
Defendant: Mylan Pharmaceuticals Inc. and Mylan Inc.
Plaintiff: Anacor Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Pfizer Inc. et al v. Mylan Pharmaceuticals Inc. et al
as 1:2019cv00752
Plaintiff: Pfizer Manufacturing Holdings LLC, Pfizer PFE Ireland Pharmaceuticals Holding 1 B.V., Pfizer Inc. and others
Defendant: Mylan Pharmaceuticals Inc. and Mylan Inc.
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation et al v. Mylan Pharmaceuticals Inc.
as 1:2019cv01042
Defendant: Mylan Pharmaceuticals Inc.
Plaintiff: Novartis Pharmaceuticals Corporation and Novartis AG
Cause Of Action: 35 U.S.C. § 271
Bristol-Myers Squibb Company et al v. Aurobindo Pharma USA Inc. We have downloadable decisions or orders for this case
as 1:2017cv00374
Defendant: Aurobindo Pharma USA Inc., Indoco Remedies Ltd., Dr. Reddy's Laboratories Inc. and others
Plaintiff: Bristol-Myers Squibb Company and Pfizer Inc.
Cause Of Action: 35 U.S.C. § 271
Merck Sharp & Dohme Corp. v. Mylan Pharmaceuticals Inc., et al.
as 1:2019cv00315
Defendant: Mylan Pharmaceuticals Inc. and Mylan Inc.
Plaintiff: Merck Sharp & Dohme Corp.
Cause Of Action: 35 U.S.C. § 271
Anacor Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc. et al
as 1:2018cv01699
Defendant: Mylan Pharmaceuticals Inc. and Mylan Inc.
Plaintiff: Anacor Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?